Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction
about
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationMechanisms of altered Ca²⁺ handling in heart failurePost-translational S-Nitrosylation Is an Endogenous Factor Fine Tuning the Properties of Human S100A1 ProteinAdeno-associated virus-mediated gene therapy in cardiovascular diseaseS100A1 in human heart failure: lack of recovery following left ventricular assist device supportCardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelS100A1 and calmodulin regulation of ryanodine receptor in striated muscleS100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapyTargeting S100A1 in heart failureS100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction couplingS100A1: Structure, Function, and Therapeutic PotentialS100A1: A novel and essential molecular component for postischemic angiogenesisS100A1: a multifaceted therapeutic target in cardiovascular diseaseSmall and large animal models in cardiac contraction research: advantages and disadvantagesG protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafishS100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial functionEffects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicityCardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overloadA novel and efficient model of coronary artery ligation and myocardial infarction in the mouse.Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage densityS100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers.Bioactive nanoparticles improve calcium handling in failing cardiac myocytes.Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction.Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.Gene therapy in heart failure.Functions of S100 proteins.S100A1 transgenic treatment of acute heart failure causes proteomic changes in rats.S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex.Induced overexpression of Na+/Ca2+ exchanger transgene: altered myocyte contractility, [Ca2+]i transients, SR Ca2+ contents, and action potential duration.Designing heart performance by gene transfer.Adeno-associated Virus Serotype 9 - Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts with Left Ventricular Dysfunction Secondary to a Myocardial Infarction.Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.Joining S100 proteins and migration: for better or for worse, in sickness and in health.
P2860
Q26799437-5708DAE5-6594-4BC7-AA27-814F8928C759Q27012758-CD9CFEC4-B70B-46FF-9BDF-CE2C68C7BADCQ27673395-651C183F-CD05-48C7-8B80-47416816181CQ28081681-5B95AB47-2DAD-40E1-83D3-517C5A4DBD04Q28240412-4B17EA6F-7B5B-4F22-AE61-FB2C5C8AFFBBQ28243737-468F41EB-989C-4CA8-BCCE-8AA93D189B85Q28243947-EABA11AD-5ECB-4502-984C-7164C505B869Q28245847-6A42BFC3-38A0-49D1-A4B7-EB1AC04E854CQ28249115-7E8A4E10-6BA0-477C-9D35-76347846C4A3Q28259868-542A0981-E4EA-4D00-8CA4-FB655C00E55FQ28261526-F6B004BD-5193-46B0-BC44-1F7B3FAA5307Q28263662-2BBF38B8-600D-412C-9CF1-1ADF5DE0A6D6Q28282541-C10E9AB3-99EC-4036-B141-53F1C389CAAAQ28288362-0DBA87F7-F1A5-4DFB-8D91-0D9A7419485CQ28658055-2A3F7DCB-06D8-4C41-9910-AE69910D4FE2Q30487539-543656AA-4A30-4FF1-BE94-BAF127D08C39Q30505441-A335A42F-3171-4441-86E2-12C5816AD724Q33757903-B54BF738-05BD-435E-85B7-69DB5C2C5157Q33917116-E8B8FBBB-3DD3-4B70-83DB-C4C0DF0E259AQ34335762-C93CED0C-9E7B-44D8-9443-A9ECEA3FD077Q34423842-B0CDAA42-7854-471B-BEE5-F71939B6AF99Q35193931-A3C830E1-8A73-4FEB-8C24-21BEF4DB2B81Q35543463-1BD91260-BC04-4F02-9D7F-FF86692961E0Q35872865-2C582ED4-388F-4D54-A721-24EC72EB7930Q36421703-F2D8309D-445A-4310-916D-BF6DA93E8638Q36547398-BD82AD11-BDB7-40AC-988D-009F69EA06FAQ36756998-E59CEF8E-A960-4634-80F3-F3F12E182200Q36801998-89C327A2-EAB7-4231-9241-1B0ECDF57546Q36837270-0337ABAD-B379-4A17-B6C4-00BEA5949734Q36874312-73FCD868-5588-4329-8457-B8E916D26150Q36883822-BA57CB91-E69C-42BE-99F5-35F931BA7F62Q36944623-72977C4D-C97F-4424-B52E-ABED1175B849Q37001259-24DF5701-A77A-4AAB-9087-0636BC9E3569Q37082922-4D186E36-8721-4D31-A010-CF76A437DC8AQ37117354-70D1DC22-BC33-40E4-B62D-2866CD57FA28Q37298277-6468D0AC-334B-4D3E-80BA-D745BDBF82EAQ37299072-4BD66611-D4FB-4BC4-9485-A0469BCB9802Q37621894-E2855B37-64A8-45DF-870B-1199E9462BC3Q38025012-701CE7EB-B15E-4C35-8783-26E974D2C59AQ38118075-C7D47D7D-7620-4A33-B924-A0888D6DE1E0
P2860
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Cardiac S100A1 protein levels ...... re after myocardial infarction
@ast
Cardiac S100A1 protein levels ...... re after myocardial infarction
@en
Cardiac S100A1 protein levels ...... re after myocardial infarction
@nl
type
label
Cardiac S100A1 protein levels ...... re after myocardial infarction
@ast
Cardiac S100A1 protein levels ...... re after myocardial infarction
@en
Cardiac S100A1 protein levels ...... re after myocardial infarction
@nl
prefLabel
Cardiac S100A1 protein levels ...... re after myocardial infarction
@ast
Cardiac S100A1 protein levels ...... re after myocardial infarction
@en
Cardiac S100A1 protein levels ...... re after myocardial infarction
@nl
P2093
P3181
P1433
P1476
Cardiac S100A1 protein levels ...... re after myocardial infarction
@en
P2093
Andrea D Eckhart
Andrew Remppis
Arthur M Feldman
Brent R DeGeorge
Hajime Funakoshi
Hanna Seifert
Jörg Heierhorst
Mirko Völkers
Patrick Most
Sven T Pleger
P304
P3181
P356
10.1161/CIRCULATIONAHA.106.622415
P407
P50
P577
2006-09-19T00:00:00Z